Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh · Delayed Price · Currency is BDT 104.30
-1.80 (-1.70%)
At close: May 6, 2026
Beacon Pharmaceuticals Market Cap
Beacon Pharmaceuticals has a market cap or net worth of 24.09 billion as of May 6, 2026. Its market cap has decreased by -16.22% in one year.
Market Cap
24.09B
Enterprise Value
30.74B
Revenue
14.78B
Ranking
n/a
PE Ratio
19.47
Stock Price
104.30
Market Cap Chart
Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 24.09B, an increase of 20.88%. That is a compound annual growth rate of 1.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 24.51B | 1.43% |
| Dec 30, 2025 | 24.16B | -23.03% |
| Dec 30, 2024 | 31.39B | -44.53% |
| Dec 28, 2023 | 56.60B | -14.34% |
| Dec 29, 2022 | 66.07B | 17.50% |
| Dec 30, 2021 | 56.23B | 210.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 186.51B |
| Beximco Pharmaceuticals PLC. | 56.21B |
| Renata | 47.62B |
| Unilever Consumer Care | 39.85B |
| The ACME Laboratories | 16.21B |
| Asiatic Laboratories | 13.56B |
| The IBN SINA Pharmaceutical Industry | 9.59B |
| Navana Pharmaceuticals | 6.29B |